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Work in our laboratory over the past several
years has demonstrated that the transplantation
of adrenal medullary chromaffin cells into the
spinal subarachnoid space can markedly reduce
pain in several rodent models without the
development of tolerance. Adrenal medullary
chromaffin cells were selected since they pro-
duce high levels of both opioid peptides and
catecholamines, agents which independently,
and possibly synergistically, reduce pain when
injected locally into the spinal subarachnoid
space. The present study was an initial attempt
to assess the potential for this approach to alle-
viate chronic pain in man.
Approval for this preliminary study was ob-
tained from the Institutional Review Board of
the University of Illinois. Consenting patients
selected for the study were suffering from pain
associated with terminal cancer with reduced
pain control by escalating doses of narcotic anal-
gesics. Human adrenal glands were obtained
from the Regional Organ Bank of Illinois, and
adrenal medullary tissue was prepared for
transplantation in our laboratory. Using sterile
techniques with the patient in the lateral decubi-
tus position, lumbar puncture using a 14-gauge
Tuohy needle was performed. After aspiration
of sufficient CSF for culture, cytology, and bio-
chemical assays, approximately 1 ml of sus-
pended adrenal medullary tissue was injected
and the needle withdrawn. Cyclosporine A (10
mg/kg orally) was administered for two weeks
beginning one day prior to the procedure.
Pain levels were determined using a Visual
Analog pain scale prior to and at weekly inter-
vals following the procedure. In addition,
records of daily analgesics consumed were kept
by the patient or patient’s family. When possible,
CSF samples were collected via lumbar puncture
at several intervals following the implantation
for cytological and biochemical analysis.
Patient i was a 61 year old female with a six
year history of carcinoma of the colon. As her
disease advanced, she developed increasing back
and lower extremity pain which became in-
tractable, despite escalating doses of narcotics.
Following transplantation, progressive decreases
in pain scores and narcotic intake were reported,
and the patient remained pain free until her
death 41/2 months following the procedure. Her
CSF met-enkephalin levels were elevated 6-fold
1 month following the procedure.
Patient 2 was a 69 year old white male with a
four-year history of carcinoma of the colon. His
pain became progressively worse and more resis-
tant to analgesic medications. The pain was
highly position dependent, in that it became
unbearable within a short period of time when
he attempted to sit up. An epidural catheter for
narcotic delivery provided significant improve-
ment in pain relief, but became infected and had
to be removed. Progressive reduction in pain
scores followed adrenal medullary transplanta-
tion, and the patient continued to be pain free
until his death 11 months later. In addition, the
patient’s activity, indicated by time spent out of
bed, improved significantly following transplan-
tation.
Patient 3 was a 49 year old Hispanic female
with a three-year history of carcinoma of the left
breast treated by mastectomy followed by
chemotherapy. Two years later she began to
complain of pain in her low back, right hip, and
buttocks which was becoming unresponsive to
narcotic analgesics. During the first month fol-
lowing adrenal medullary implantation, the
patient’s pain scores decreased dramatically.
However, at this point the patient began to
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complain of progressive weakness of her lower
extremities and a CT scan/myelogram revealed a
spinal block due to metastasis. Since that time
the patient had a recurrence of her pain.
Patient 4 was a 57 year old Hispanic male
with a three-year history of colon carcinoma,
initially treated by surgical resection followed by
chemotherapy and radiation therapy. He did
well until he developed pain in the sacral area
which became unresponsive to increasing doses
of narcotic analgesics. Following implantation,
the patient’s pain scores fell rapidly, and by the
end of three weeks, the patient had eliminated
all narcotic intake. CSF levels of both nor-
epinephrine and met-enkephalin were signifi-
cantly increased. At the end of the 10th month
following the procedure, the patient still
remained pain free.
At least three of the patients in this pre-
liminary clinical study obtained significant, long-
lasting pain relief following adrenal medullary
transplantation in the spinal subarachnoid space.
A fourth patient obtained similar relief early, but
her pain returned, possibly due to complications
resulting from spinal cord compression
secondary to metastasis. The mechanism for
pain reduction by adrenal medullary transplants
may be via increases in opioid peptide and cate-
cholamine levels. The encouraging results of this
initial pilot study suggest that adrenal medullary
transplantation may provide a unique and effec-
tive approach in the management of pain in
man.
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